Floatz logo

Alpha-Type-1 Polarized Dendritic Cells

Stage II Ovarian Cancer AJCC v8

Roswell Park Cancer InstituteCell therapyPhase 1/2Active
C
34/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
19/ 100
Competitive Position
95/ 100

Competitive context

244 Active assets in the Stage II Ovarian Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
Trabectedin
AGO Research GmbH
Phase 4BBB
Mirvetuximab Soravtansine
AstraZeneca
Phase 3BBB
Olaparib
Imunon
Phase 4BB
Irinotecan
OHSU Knight Cancer Institute
Phase 2BB
Carboplatin
University of Washington
Phase 3BB

View all 50 →

Same molecule, other indications

Alpha-Type-1 Polarized Dendritic Cells is also rated in:

breast cancerDormant
C
Indicative ·
37 / 100
View asset →
triple-negative breast carcinomaDormant
C
Indicative ·
37 / 100
View asset →
HLA-A2 Positive Cells PresentDormant
C
Indicative ·
37 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →